Allscripts Announces First Quarter of 2022 Results

Go back to Allscripts Announces First Quarter of 2022 Results

Allscripts (MDRX) Misses Q1 EPS by 10c; Affirms Outlook

May 5, 2022 4:04 PM EDT

Allscripts (NASDAQ: MDRX) reported Q1 EPS of $0.13, $0.10 worse than the analyst estimate of $0.23. Revenue for the quarter came in at $143 million, versus $133.7 million reported last year.

GUIDANCE:

Allscripts is affirming its prior annual outlook and currently expects to achieve:

Veradigm revenue... More